Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions revolve around the potential clinical impact of the study, as evidenced by posts like 'what's your opinion about these estimations?' and references to the article's focus on therapeutic effect sizes. The tone is analytical yet optimistic, emphasizing the importance of the findings for advancing CHD treatments and interpreting genetic data for practical use.
Most discussions acknowledge the importance of the study and its findings, with some opinions supporting the idea that understanding Lp(a) lowering is crucial for CHD risk reduction.
Posts show moderate curiosity, focusing on the significance of the estimates for future therapies and clinical implications.
Comments demonstrate some active participation, including questions and references to methodological approaches, indicating a reasonable level of engagement.
The discussions suggest potential influence on research and clinical practices, with mentions of guiding therapeutic targets and future treatments.
@Lpa_Doc Thx Sam. What’s your opinion about these estimations? https://t.co/5h3mj5Bbxs https://t.co/E1DpkRVZ4V https://t.co/RKXQLJREu5
Estimation of the required lipoprotein(a)-lowering therapeutic effect size for reduction in coronary heart disease outcomes: a mendelian randomization analysis @lipoproteinaFDN @lipiddoc @Lpa_Doc https://t.co/vPsD5SR9gm
Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis. https://t.co/I4EYLWcAHL
RT @Mendelian_lit: Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outco…
RT @drpablocorral: @Lpa_Doc Thx Sam. What’s your opinion about these estimations? https://t.co/5h3mj5Bbxs https://t.co/E1DpkRVZ4V https:/…
RT @drpablocorral: @Lpa_Doc Thx Sam. What’s your opinion about these estimations? https://t.co/5h3mj5Bbxs https://t.co/E1DpkRVZ4V https:/…
Prof. Dr. Florian Kronenberg discusses the significance of diagnosing and managing Lp(a) hyperlipoproteinemia in preventing cardiovascular diseases. The video elaborates on the European Atherosclerosis Society's…
This video discusses the recent study analyzing how much lipoprotein(a) (Lp(a)) levels need to be lowered to significantly reduce coronary heart disease risk, using genetic data and Mendelian randomization analysis. It…
RT @drpablocorral: @Lpa_Doc Thx Sam. What’s your opinion about these estimations? https://t.co/5h3mj5Bbxs https://t.co/E1DpkRVZ4V https:/…
RT @drpablocorral: @Lpa_Doc Thx Sam. What’s your opinion about these estimations? https://t.co/5h3mj5Bbxs https://t.co/E1DpkRVZ4V https:/…
@Lpa_Doc Thx Sam. What’s your opinion about these estimations? https://t.co/5h3mj5Bbxs https://t.co/E1DpkRVZ4V https://t.co/RKXQLJREu5
Estimation of the required lipoprotein(a)-lowering therapeutic effect size for reduction in coronary heart disease outcomes: a mendelian randomization analysis @lipoproteinaFDN @lipiddoc @Lpa_Doc https://t.co/vPsD5SR9gm
RT @Mendelian_lit: Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outco…
Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis. https://t.co/I4EYLWcAHL